Nicholas S. Reed AuD PhD 1,2 Alison R. Huang PhD 2 Jennifer A. Deal PhD 2 1 Amplifon SpA, Milan, Italy 2 Cochlear Center for Hearing and Public Health, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Readers of CanadianAudiologist.ca likely know that hearing loss has important consequences for health....
Continue reading at Canadian Audiologist
✦ The floor
Discussion
Signed responses from readers of the wire.
Audiologists should be aware that OTC hearing aids are now an established part of the U.S. landscape; review findings to counsel patients who present having already self-fitted a device.
The four-year review of OTC hearing aid policy provides the field's first substantive evidence base for evaluating whether deregulation improved hearing healthcare access and outcomes at a population level.
- 01Authors from Johns Hopkins and Amplifon conducted a public health review of OTC hearing aids four years post-regulation.
- 02The review assesses uptake, access equity, and outcomes since OTC devices became available in the U.S.
- 03Amplifon co-authorship signals potential industry perspective alongside academic analysis.
- 04Findings are relevant to Canadian audiologists as a comparator to regulated prescription models.
- 05Review covers both benefits and ongoing challenges of OTC hearing aid access.
Over-the-counter hearing aids have been available in the United States for four years following regulatory introduction.
guidelinesupportedOTC hearing aids have had measurable public health implications since their introduction.
studypartially supported- Publication type
- review
- Evidence level
- 5
- Population
- U.S. population with hearing loss accessing OTC hearing aids
- Intervention
- Over-the-counter hearing aids
- Comparator
- Prescription hearing aid pathway
Primary outcomes
Public health impact of OTC hearing aid availability; Access and equity outcomes; Uptake rates post-regulation
